- Home
- PVLA vs GENI Comparison
PVLA vs GENI Comparison
Compare PVLA & GENI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PVLA | GENI |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | United States | United Kingdom |
| Employees | 14 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | PVLA | GENI |
|---|---|---|
| Price | $127.43 | $4.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 16 |
| Target Price | ★ $171.87 | $12.75 |
| AVG Volume (30 Days) | 160.9K | ★ 4.3M |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $24.00 |
| Revenue Next Year | $104,350.18 | $20.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $20.20 | $3.83 |
| 52 Week High | $151.18 | $13.73 |
Technical Indicators
Market Signals| Indicator | PVLA | GENI |
|---|---|---|
| Relative Strength Index (RSI) | 55.58 | 46.42 |
| Support Level | $108.99 | $3.83 |
| Resistance Level | $135.23 | $5.05 |
| Average True Range (ATR) | 6.85 | 0.23 |
| MACD | -0.17 | 0.04 |
| Stochastic Oscillator | 59.42 | 30.29 |
Price Performance
Historical ComparisonAbout PVLA Palvella Therapeutics Inc.
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
About GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.